ALVO Alvotech

NASDAQ

$4.67

Alvotech (ALVO) is confirmed to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +20.1% since its last earnings release on August 19, 2026.

Alvotech Missed Consensus Estimates, Reaffirms

Wednesday, August 19, 2026 · 4:30 PM ET

3rd Quarter, Sep 2026

Wednesday · 4:30 PM ET

Earnings Whisper

-

vs ($0.01)

Rev est $137.09M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $5.31

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alvotech

Alvotech is a biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.